Lazertinib (mesylate), CAS [[2247995-37-3]]

Product Overview

• Article Name: Lazertinib (mesylate), CAS [[2247995-37-3]]
• Biozol Catalog Number: MCE-HY-109061B
• Supplier Catalog Number: HY-109061B
• Alternative Catalog Number: MCE-HY-109061B-5MG,MCE-HY-109061B-10MG,MCE-HY-109061B-25MG,MCE-HY-109061B-50MG,MCE-HY-109061B-100MG,MCE-HY-109061B-10MMX1ML
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: YH25448 (mesylate), GNS-1480 (mesylate)

Product Description

Lazertinib (mesylate) (YH25448 (mesylate), GNS-1480 (mesylate)) is an orally active EGFR inhibitor that can penetrate the blood-brain barrier. Lazertinib (mesylate) inhibits p-EGFR, p-AKT and p-ERK signaling pathways, leading to apoptosis. Lazertinib (mesylate) has anti-tumor activity in the mouse H1975-luc BM xenograft model. Lazertinib (mesylate) can be used in the study of non-small cell lung cancer[1].

Product Properties

• Molecular Weight: 650.75
• Purity: 99.85
• CAS Number: [2247995-37-3]
• Formula: C31H38N8O6S
• Target: Akt,EGFR,ERK

Application Notes

• Application Notes: MCE Product type: Reference compound1